190 related articles for article (PubMed ID: 23197749)
1. Ataxin-1 and ataxin-2 intermediate-length PolyQ expansions in amyotrophic lateral sclerosis.
Conforti FL; Spataro R; Sproviero W; Mazzei R; Cavalcanti F; Condino F; Simone IL; Logroscino G; Patitucci A; Magariello A; Muglia M; Rodolico C; Valentino P; Bono F; Colletti T; Monsurrò MR; Gambardella A; La Bella V
Neurology; 2012 Dec; 79(24):2315-20. PubMed ID: 23197749
[TBL] [Abstract][Full Text] [Related]
2. The modulation of Amyotrophic Lateral Sclerosis risk by ataxin-2 intermediate polyglutamine expansions is a specific effect.
Gispert S; Kurz A; Waibel S; Bauer P; Liepelt I; Geisen C; Gitler AD; Becker T; Weber M; Berg D; Andersen PM; Krüger R; Riess O; Ludolph AC; Auburger G
Neurobiol Dis; 2012 Jan; 45(1):356-61. PubMed ID: 21889984
[TBL] [Abstract][Full Text] [Related]
3. Ataxin-2 intermediate-length polyglutamine expansions in European ALS patients.
Lee T; Li YR; Ingre C; Weber M; Grehl T; Gredal O; de Carvalho M; Meyer T; Tysnes OB; Auburger G; Gispert S; Bonini NM; Andersen PM; Gitler AD
Hum Mol Genet; 2011 May; 20(9):1697-700. PubMed ID: 21292779
[TBL] [Abstract][Full Text] [Related]
4. Ataxin-2 polyQ expansions in FTLD-ALS spectrum disorders in Flanders-Belgian cohorts.
Van Langenhove T; van der Zee J; Engelborghs S; Vandenberghe R; Santens P; Van den Broeck M; Mattheijssens M; Peeters K; Nuytten D; Cras P; De Deyn PP; De Jonghe P; Cruts M; Van Broeckhoven C
Neurobiol Aging; 2012 May; 33(5):1004.e17-20. PubMed ID: 22035589
[TBL] [Abstract][Full Text] [Related]
5. PolyQ repeat expansions in ATXN2 associated with ALS are CAA interrupted repeats.
Yu Z; Zhu Y; Chen-Plotkin AS; Clay-Falcone D; McCluskey L; Elman L; Kalb RG; Trojanowski JQ; Lee VM; Van Deerlin VM; Gitler AD; Bonini NM
PLoS One; 2011 Mar; 6(3):e17951. PubMed ID: 21479228
[TBL] [Abstract][Full Text] [Related]
6. ATAXIN2 CAG-repeat length in Italian patients with amyotrophic lateral sclerosis: risk factor or variant phenotype? Implication for genetic testing and counseling.
Gellera C; Ticozzi N; Pensato V; Nanetti L; Castucci A; Castellotti B; Lauria G; Taroni F; Silani V; Mariotti C
Neurobiol Aging; 2012 Aug; 33(8):1847.e15-21. PubMed ID: 22425256
[TBL] [Abstract][Full Text] [Related]
7. Evaluating the prevalence of polyglutamine repeat expansions in amyotrophic lateral sclerosis.
Lee T; Li YR; Chesi A; Hart MP; Ramos D; Jethava N; Hosangadi D; Epstein J; Hodges B; Bonini NM; Gitler AD
Neurology; 2011 Jun; 76(24):2062-5. PubMed ID: 21562248
[TBL] [Abstract][Full Text] [Related]
8. Distinct TDP-43 pathology in ALS patients with ataxin 2 intermediate-length polyQ expansions.
Hart MP; Brettschneider J; Lee VM; Trojanowski JQ; Gitler AD
Acta Neuropathol; 2012 Aug; 124(2):221-30. PubMed ID: 22526021
[TBL] [Abstract][Full Text] [Related]
9. ATXN-2 CAG repeat expansions are interrupted in ALS patients.
Corrado L; Mazzini L; Oggioni GD; Luciano B; Godi M; Brusco A; D'Alfonso S
Hum Genet; 2011 Oct; 130(4):575-80. PubMed ID: 21537950
[TBL] [Abstract][Full Text] [Related]
10. Expanded ATXN2 CAG repeat size in ALS identifies genetic overlap between ALS and SCA2.
Van Damme P; Veldink JH; van Blitterswijk M; Corveleyn A; van Vught PW; Thijs V; Dubois B; Matthijs G; van den Berg LH; Robberecht W
Neurology; 2011 Jun; 76(24):2066-72. PubMed ID: 21562247
[TBL] [Abstract][Full Text] [Related]
11. Evaluating noncoding nucleotide repeat expansions in amyotrophic lateral sclerosis.
Figley MD; Thomas A; Gitler AD
Neurobiol Aging; 2014 Apr; 35(4):936.e1-4. PubMed ID: 24269018
[TBL] [Abstract][Full Text] [Related]
12. ALS-associated ataxin 2 polyQ expansions enhance stress-induced caspase 3 activation and increase TDP-43 pathological modifications.
Hart MP; Gitler AD
J Neurosci; 2012 Jul; 32(27):9133-42. PubMed ID: 22764223
[TBL] [Abstract][Full Text] [Related]
13. Hexanucleotide repeat expansions in C9ORF72 in the spectrum of motor neuron diseases.
van Rheenen W; van Blitterswijk M; Huisman MH; Vlam L; van Doormaal PT; Seelen M; Medic J; Dooijes D; de Visser M; van der Kooi AJ; Raaphorst J; Schelhaas HJ; van der Pol WL; Veldink JH; van den Berg LH
Neurology; 2012 Aug; 79(9):878-82. PubMed ID: 22843265
[TBL] [Abstract][Full Text] [Related]
14. ATXN2 polyQ intermediate repeats are a modifier of ALS survival.
Chiò A; Calvo A; Moglia C; Canosa A; Brunetti M; Barberis M; Restagno G; Conte A; Bisogni G; Marangi G; Moncada A; Lattante S; Zollino M; Sabatelli M; Bagarotti A; Corrado L; Mora G; Bersano E; Mazzini L; D'Alfonso S;
Neurology; 2015 Jan; 84(3):251-8. PubMed ID: 25527265
[TBL] [Abstract][Full Text] [Related]
15. Ataxin-2 intermediate-length polyglutamine: a possible risk factor for Chinese patients with amyotrophic lateral sclerosis.
Chen Y; Huang R; Yang Y; Chen K; Song W; Pan P; Li J; Shang HF
Neurobiol Aging; 2011 Oct; 32(10):1925.e1-5. PubMed ID: 21741123
[TBL] [Abstract][Full Text] [Related]
16. Association of long ATXN2 CAG repeat sizes with increased risk of amyotrophic lateral sclerosis.
Daoud H; Belzil V; Martins S; Sabbagh M; Provencher P; Lacomblez L; Meininger V; Camu W; Dupré N; Dion PA; Rouleau GA
Arch Neurol; 2011 Jun; 68(6):739-42. PubMed ID: 21670397
[TBL] [Abstract][Full Text] [Related]
17. Ataxin-2 interacts with FUS and intermediate-length polyglutamine expansions enhance FUS-related pathology in amyotrophic lateral sclerosis.
Farg MA; Soo KY; Warraich ST; Sundaramoorthy V; Blair IP; Atkin JD
Hum Mol Genet; 2013 Feb; 22(4):717-28. PubMed ID: 23172909
[TBL] [Abstract][Full Text] [Related]
18. C9orf72 hexanucleotide repeat expansions and Ataxin 2 intermediate length repeat expansions in Indian patients with amyotrophic lateral sclerosis.
Narain P; Gomes J; Bhatia R; Singh I; Vivekanandan P
Neurobiol Aging; 2017 Aug; 56():211.e9-211.e14. PubMed ID: 28527524
[TBL] [Abstract][Full Text] [Related]
19. Frequency of C9orf72 repeat expansions in amyotrophic lateral sclerosis: a Belgian cohort study.
Debray S; Race V; Crabbé V; Herdewyn S; Matthijs G; Goris A; Dubois B; Thijs V; Robberecht W; Van Damme P
Neurobiol Aging; 2013 Dec; 34(12):2890.e7-2890.e12. PubMed ID: 23870417
[TBL] [Abstract][Full Text] [Related]
20. Motor neurone disease/amyotrophic lateral sclerosis associated with intermediate-length CAG repeat expansions in Ataxin-2 does not have 1C2-positive polyglutamine inclusions.
Highley JR; Lorente Pons A; Cooper-Knock J; Wharton SB; Ince PG; Shaw PJ; Wood J; Kirby J
Neuropathol Appl Neurobiol; 2016 Jun; 42(4):377-89. PubMed ID: 26095883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
